Skip to search formSkip to main contentSkip to account menu

INNO-406

Known as: Benzamide, N-[3-([4,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3- (dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)-, CNS-9 
National Institutes of Health

Related topics

Related topics

2 relations
NS-187

Broader (1)

bafetinib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
system, and cyclosporine A augments its in vivo activity leukemia cells in the central nervous + suppresses the growth of Ph INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor,
doi:10.1182/blood-2006-03-013250 Prepublished online Sep 5, 2006;2007 109: 306-314€€€€Takanori Ueda, Kiyohiko Hatake, Ken-ichi… 
2009
2009
Inibidores de tirosino quinase na leucemia mieloide crônica
A leucemia mieloide cronica (LMC) e uma neoplasia da medula ossea originada da translocacao entre os cromossomos 9 e 22 t(9:22… 
2009
2009
INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph[+] leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity
2007
2007
Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines